Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Jazz Pharmaceuticals PLC
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products.

It has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd on January 18, 2012 and is headquartered in Dublin, Ireland.

Number of employees : 910 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceutical Products1,173100%1,325100% +12.95%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States1,00785.9%1,19390% +18.41%
Europe126.7210.8%103.617.8% -18.23%
All Other38.763.3%28.312.1% -26.97%
Managers
NameAgeSinceTitle
Bruce C. Cozadd, MBA522012Chairman & Chief Executive Officer
Russell J. Cox542012Chief Operating Officer & Executive Vice President
Matthew P. Young, MBA482013Chief Financial Officer & Executive Vice President
Karen L. Smith MD, PhD492015Chief Medical Officer, Global Head-R&D
Paul L. Berns502010Independent Class II Director
Patrick G. Enright, MBA552012Independent Director
Seamus C. Mulligan562012Independent Director
Ken W. O'Keefe, MBA502012Independent Director
Rick E. Winningham, MBA572012Lead Independent Director
Catherine Angell Sohn, PhD632012Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 59,892,335 58,498,968 97.7% 0 0.0% 97.7%
Shareholders
NameEquities%
Putnam Investment Management LLC 7,668,086 12.8%
Fidelity Management & Research Co. 7,389,585 12.3%
The Vanguard Group, Inc. 4,371,250 7.30%
BlackRock Fund Advisors 2,217,300 3.70%
Renaissance Technologies LLC 1,560,300 2.61%
Cadian Capital Management LP 1,540,782 2.57%
Westfield Capital Management Co. LP 1,259,389 2.10%
FIL Investment Advisors (UK) Ltd 1,224,757 2.04%
Seamus C. Mulligan 1,048,008 1.75%
Janus Capital Management LLC 999,112 1.67%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Specialty & Advanced Pharmaceuticals
Advertisement
Sector Specialty & Advanced Pharmaceuticals
1st jan.Capitalization (M$)
JAZZ PHARMACEUTICALS P..24.67%8 082
ABBVIE INC-1.26%97 803
MERCK KGAA3.88%14 053
KYOWA HAKKO KIRIN CO L..5.56%8 585
MALLINCKRODT PLC8.61%5 675
ZHANGZHOU PIENTZEHUANG..0.79%4 177
INDIVIOR PLC24.51%3 101
YUHAN CORPORATION--.--%2 190
MAYNE PHARMA GROUP LTD4.09%1 705
ADVANCED ACCELERATOR A..--.--%1 596
SUPERNUS PHARMACEUTICA..2.38%1 258
KNIGHT THERAPEUTICS IN..1.21%1 182
EAGLE PHARMACEUTICALS ..-7.25%1 115
THERAPEUTICSMD INC-3.12%1 115
REPLIGEN CORPORATION-1.10%1 093
AIMMUNE THERAPEUTICS I..-1.86%988
NICHI-IKO PHARMACEUTIC..3.29%917
DONG-A ST CO LTD--.--%708
STALLERGENES GREER0.16%647
RECIPHARM AB (PUBL)-2.27%630
AB SCIENCE8.55%597
Sector Specialty & Advanced Pharmaceuticals
Jazz Pharmaceuticals PLC : Connections
Vascular Cures
Beecken Petty O'Keefe & Co. LP
CHD Bioscience, Inc.
Adapt Pharma Ltd.
Ariel Pharmaceuticals, Inc.
Longitude Capital Management Co. LLC
World Affairs Council of Philadelphia
Circ Pharma Ltd.
Jazz Pharmaceuticals, Inc.
Pharmaceutical Research & Manufacturers of America
SutroVax, Inc.
Sohn Health Strategies LLC
Orbus Therapeutics, Inc.
Nueva School
Aptinyx, Inc.
InfaCare Pharmaceutical Corp.
Raven Biotechnologies, Inc.
University of the Sciences in Philadelphia
Company contact information
Jazz Pharmaceuticals Plc
Connaught House
One Burlington Road
4th Floor
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
© 2017 People , Fundamentals and Ownership